We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.65B
AUM Growth
+$158M
Cap. Flow
-$37.9M
Cap. Flow %
-2.29%
Top 10 Hldgs %
48.4%
Holding
142
New
11
Increased
37
Reduced
35
Closed
5

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$15.6M
2
CRM icon
Salesforce
CRM
+$3.28M
3
DKNG icon
DraftKings
DKNG
+$3.2M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.24M
5
META icon
Meta Platforms (Facebook)
META
+$2.11M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10M
3
CI icon
Cigna
CI
+$9.59M
4
IBM icon
IBM
IBM
+$7.63M
5
NTAP icon
NetApp
NTAP
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 38.78%
2 Communication Services 14.27%
3 Healthcare 14.18%
4 Consumer Discretionary 14.17%
5 Financials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$950B
$19.9M 1.2%
156,252
+139,252
+819% +$15.6M
CTXS
27
DELISTED
Citrix Systems Inc
CTXS
$19.5M 1.18%
149,990
– –
PFE icon
28
Pfizer
PFE
$144B
$19.2M 1.16%
521,083
-75,975
-13% -$2.79M
ZBH icon
29
Zimmer Biomet
ZBH
$18.5B
$18.5M 1.12%
123,627
+15,893
+15% +$2.24M
NXPI icon
30
NXP Semiconductors
NXPI
$65.4B
$18.1M 1.09%
113,670
– –
AKAM icon
31
Akamai
AKAM
$16.3B
$15.9M 0.96%
151,140
– –
CTSH icon
32
Cognizant
CTSH
$23.8B
$14.7M 0.89%
179,925
+965
+0.5% +$73.4K
LH icon
33
Labcorp
LH
$25.8B
$14.4M 0.87%
82,231
+6,175
+8% +$1.07M
ILMN icon
34
Illumina
ILMN
$29.2B
$14M 0.84%
38,814
+1,233
+3% +$393K
CHKP icon
35
Check Point Software Technologies
CHKP
$14.1B
$13.3M 0.8%
100,143
– –
CRM icon
36
Salesforce
CRM
$149B
$13.2M 0.8%
59,205
+13,505
+30% +$3.28M
ACN icon
37
Accenture
ACN
$101B
$12.5M 0.76%
47,897
– –
GNTX icon
38
Gentex
GNTX
$5.12B
$11.6M 0.7%
341,980
+4,480
+1% +$138K
NTAP icon
39
NetApp
NTAP
$34.2B
$11M 0.67%
166,765
-98,600
-37% -$5.21M
PYPL icon
40
PayPal
PYPL
$51.4B
$10.6M 0.64%
45,415
– –
DKNG icon
41
DraftKings
DKNG
$12.2B
$10.6M 0.64%
226,735
+67,230
+42% +$3.2M
MCK icon
42
McKesson
MCK
$104B
$10.2M 0.62%
58,877
– –
MDT icon
43
Medtronic
MDT
$111B
$8.62M 0.52%
73,611
– –
ISRG icon
44
Intuitive Surgical
ISRG
$130B
$8.4M 0.51%
30,810
+2,070
+7% +$514K
DOX icon
45
Amdocs
DOX
$5.83B
$8.14M 0.49%
114,757
-9,815
-8% -$616K
STT icon
46
State Street
STT
$50.2B
$7.83M 0.47%
107,570
-19,710
-15% -$1.34M
HPQ icon
47
HP
HPQ
$25.9B
$7.7M 0.47%
313,241
-150,000
-32% -$3.15M
PEP icon
48
PepsiCo
PEP
$195B
$7.54M 0.46%
50,820
-11,487
-18% -$1.63M
GSK icon
49
GSK
GSK
$108B
$7.13M 0.43%
154,936
-14,516
-9% -$667K
GILD icon
50
Gilead Sciences
GILD
$167B
$6.87M 0.42%
117,940
-180,120
-60% -$10.9M
1
2
3 4 5

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Oak Associates held 142 positions worth $1.65B, up 11% from $1.5B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Oak Associates's Q4 2020 filing shows 11 new, 37 increased, 35 reduced and 5 closed positions. Its largest new stake was Exelixis: 96,090 shares worth $1.93M. The largest sale was Gilead Sciences, an estimated $10.9M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 38% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q4 2020 buy was Exelixis: 96,090 shares worth $1.93M.
  • Oak Associates added most to JPMorgan Chase in Q4 2020, an estimated $15.6M increase.
  • Oak Associates's biggest Q4 2020 reduction was Gilead Sciences, cutting an estimated $10.9M.
  • Oak Associates fully exited Juniper Networks in Q4 2020, selling an estimated $1.17M.
  • Oak Associates's ten largest holdings make up 48% of its $1.65B portfolio in Q4 2020.
  • Oak Associates opened 11 new positions and closed 5 in Q4 2020.
  • Oak Associates's portfolio value rose 11% quarter-over-quarter to $1.65B.

Based on Oak Associates's 13F filing for Q4 2020, filed 12 Feb 2021.